Warby Parker (WRBY)
(Delayed Data from NYSE)
$14.79 USD
+0.11 (0.75%)
Updated May 10, 2024 04:00 PM ET
After-Market: $14.78 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum A VGM
Price, Consensus and EPS Surprise
WRBY 14.79 +0.11(0.75%)
Will WRBY be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for WRBY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for WRBY
Warby Parker (WRBY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zimmer Biomet (ZBH) Beats Q1 Earnings and Revenue Estimates
WRBY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Warby Parker Inc. (WRBY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Warby Parker Inc. (WRBY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Pre-Markets in the Green Ahead of CPI Data Release
Other News for WRBY
Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunocore Holdings (IMCR), Warby Parker (WRBY) and Ocular Therapeutix (OCUL)
JMP Securities Remains a Hold on Warby Parker (WRBY)
Warby Parker Q1 2024 Earnings: Revenue Surges, Beats Estimates
Telsey Advisory Remains a Buy on Warby Parker (WRBY)
Warby Parker price target raised by $2 at UBS, here's why